Skip to content

The effect of diabetes on oral implants in elderly patients - A prospective cohort study

The effect of diabetes on the prognosis and safety of oral implant surgery in elderly patients - A prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107000
Enrollment
Unknown
Registered
2025-08-01
Start date
2025-08-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth loss

Interventions

Exposure group:None
Control group:None

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for the exposure group: (1) Age 60-90 years old (including 60 and 90 years old); ? The patient requests dental implant restoration,and the implant surgery is under local anesthesia; ? The patient has type 2 diabetes and with a standardized treatment duration of >=3 months; ? The patient participate in the research voluntarily, cooperate with the examination and sign the informed consent form. 2.Inclusion criteria for the control group: Age 60-90 years old (including 60 and 90 years old); ? The patient requests dental implant restoration,and the implant surgery is under local anesthesia;? No diabetes; ? The patient participate in the research voluntarily, cooperate with the examination and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are obvious oral abscesses, precancerous lesions, fungal infections and pericoronitis of wisdom teeth throughout the mouth, and there is active or uncontrolled periodontal disease; 2.Patients who have experienced myocardial infarction or heart failure within 6 months; 3.Patients with hypertension; 4.Patients who have had cerebrovascular accidents within three months; 5.There are coagulation disorders, thrombocytopenia, hemophilia or significant anemia; 6. Glycated hemoglobin > 10%; 7.There is a history of intravenous use of bisphosphonates; 8.Those using immunosuppressants, including high-dose glucocorticoids (prednisone/prednisone > 10mg per day); 9. Malignant tumors that have not received standardized treatment, or have received standardized treatment for less than five years; 10.Those diagnosed with acquired immunodeficiency syndrome, syphilis and hepatitis B, who have not received standardized treatment and control; 11. Patients with severe cognitive impairment (dementia), schizophrenia, and severe depression.

Design outcomes

Primary

MeasureTime frame
The incidence of peri-implantitis one year after the completion of implant restoration;

Secondary

MeasureTime frame
Local safety;The score results of the cognitive scale one year after implant restoration;Systemic safety during the perioperative period;The incidence of complications of the implant one year after implant restoration surgery;Subjective evaluation of patients one year after implant restoration;The fluctuation range of blood glucose during the perioperative period;

Countries

China

Contacts

Public ContactDuohong Zou

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

zouduohongyy@163.com+86 13601645549

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026